Breakthrough therapies for autoimmune disorders

4immune’s platform technology addresses a broad range of T cell-mediated autoimmune disorders, including type 1 diabetes.

Using a novel combination of FDA approved CAR T cells and unique antigens, our Chimeric Antigen Ligand T Cell Therapy (CAL / CAR T Cell Therapy) has the potential to change the future of autoimmune disorders by targeting and destroying specific disease-causing cells.

Seeing Type 1 Diabetes through a new lens

We approach type 1 diabetes with a focus on early interception, before irreparable damage has been done.

Our CAL/CAR T Cell Therapy specifically targets and destroys the autoreactive T cells responsible for the destruction of healthy cells to restore homeostasis and change the course of the life-long debilitating disease.

A team that is dedicated to changing the paradigm of autoimmune disorders.

We are committed scientific pioneers and renowned industry leaders looking outside of conventional measures to develop powerful therapies for heretofore incurable autoimmune diseases.